Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
127 hedge funds and large institutions have $411M invested in Surmodics in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 49 reducing their positions, and 25 closing their positions.
1.51% more ownership
Funds ownership: 89.24% → 90.74% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 143 → 127 (-16)
18% less capital invested
Capital invested by funds: $502M → $411M (-$91.5M)
18% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 49
56% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$15.6M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.84M |
| 3 |
Goldman Sachs
New York
|
+$2.05M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.83M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$2.78M |
| 2 |
BlackRock
New York
|
-$2.65M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.43M |
| 4 |
Two Sigma Investments
New York
|
-$1.4M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$1.22M |
SRDX Hedge Fund Activity: Q1 2020 in Review
127 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q1 2020, worth a combined $411M — down 18% from $502M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of SRDX and 11 opened new positions — a net loss of 14 holders — while 49 trimmed existing stakes and 40 added.
The largest buyer was Trigran Investments, adding an estimated $15.6M. The largest seller was Panagora Asset Management, cutting an estimated $2.78M.
- 127 institutional investors held Surmodics (SRDX) as of Q1 2020, down from 143 in Q4 2019.
- Funds reported $411M of Surmodics stock for Q1 2020, down 18% quarter-over-quarter.
- 11 funds opened new Surmodics positions in Q1 2020 and 25 closed out, a net change of -14 holders.
- The largest Surmodics buyer in Q1 2020 was Trigran Investments, an estimated $15.6M added.
- The largest Surmodics seller in Q1 2020 was Panagora Asset Management, an estimated $2.78M sold.
Based on aggregated 13F filings for Q1 2020.